Atai Life Sciences (ATAI) News Today $1.59 -0.14 (-8.09%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Atai Life Sciences price target lowered to $10 from $15 at H.C. WainwrightNovember 19 at 12:41 AM | markets.businessinsider.comATAI Life Sciences: Buy Rating Affirmed Amid Promising Pipeline and Financial EfficiencyNovember 19 at 12:41 AM | markets.businessinsider.comATAI Life Sciences: Strategic Advancements and Strong Financials Underpin Buy RatingNovember 17, 2024 | markets.businessinsider.comAtai Q3 Report: Strong Cash Position, Clinical Pipeline GrowthNovember 14, 2024 | benzinga.comTD Cowen Sticks to Its Buy Rating for ATAI Life Sciences (ATAI)November 14, 2024 | markets.businessinsider.comatai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNovember 14, 2024 | finance.yahoo.comAtai Life Sciences Advances Psychedelic Treatments in Q3 2024November 14, 2024 | markets.businessinsider.comatai Life Sciences shares set to be lifted by 2025 trial data readouts: analystsNovember 14, 2024 | proactiveinvestors.comatai Life Sciences advances therapeutic pipeline in Q3 with FDA approval of VLS-01November 13, 2024 | proactiveinvestors.comRFK Jr's appointment in health could accelerate psychedelic drug development, analysts sayNovember 12, 2024 | proactiveinvestors.comMassachusetts psychedelics legalization initiative poised to failNovember 6, 2024 | msn.comATAI Life Sciences (NASDAQ:ATAI) Stock, Insider Trading ActivityOctober 15, 2024 | benzinga.comatai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 15, 2024 | finance.yahoo.comCould Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says YesOctober 8, 2024 | benzinga.comATAI Life Sciences completes acquisition of IntelGenx Corp.October 6, 2024 | investing.comIntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AGOctober 2, 2024 | globenewswire.comAtai Life Sciences N.V. (9VC.DE)September 18, 2024 | sg.finance.yahoo.comBiologists find that hardship early in life can affect health and longevity—even for marmotsSeptember 17, 2024 | msn.comATAI Atai Life Sciences N.V.September 14, 2024 | seekingalpha.comatai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comBuy Rating Affirmed for ATAI Life Sciences Amid Progress in Neurology Pipeline and Potential Market OpportunitiesAugust 31, 2024 | markets.businessinsider.comAtai Life Sciences N.V. (9VC.F)August 28, 2024 | uk.finance.yahoo.comATAI Sep 2024 2.500 put (ATAI240920P00002500)August 18, 2024 | finance.yahoo.comatai Life Sciences chief scientific officer details VLS-01 trial success - ICYMIAugust 17, 2024 | proactiveinvestors.comBuy Rating Affirmed for ATAI Life Sciences with Promising Clinical Outlook and Strategic Pipeline ReprioritizationAugust 17, 2024 | markets.businessinsider.comPositive Outlook for ATAI Life Sciences Amidst Upcoming Clinical Trials and Strategic CollaborationsAugust 17, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Achieve Life Sciences (ACHV)August 15, 2024 | markets.businessinsider.comStrong Buy Rating for ATAI Life Sciences on Promising Clinical Data and Solid FinancialsAugust 15, 2024 | markets.businessinsider.comatai Life Sciences entering catalyst-rich period with key Phase2/3 trial data aheadAugust 14, 2024 | proactiveinvestors.comPsychedelic drug contender stocks drop after FDA rejects MDMA treatmentAugust 13, 2024 | msn.comFDA Rejection of MDMA Therapy Isn’t End of Psychedelic-Drug CandidatesAugust 13, 2024 | msn.comatai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)August 13, 2024 | finance.yahoo.comatai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | finance.yahoo.comatai Life Sciences advances clinical pipeline in Q2, unveils positive VLS-01 trial resultsAugust 13, 2024 | proactiveinvestors.comatai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | globenewswire.comFDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks UnchangedAugust 12, 2024 | seekingalpha.comatai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth ConferenceAugust 7, 2024 | globenewswire.comOpenAI announces SearchGPT to rival Google - Tech & Science Daily podcastJuly 27, 2024 | ca.news.yahoo.comSergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatmentsJuly 24, 2024 | finance.yahoo.comGoogle co-founder backs biotech studying psychedelic African shrubJuly 22, 2024 | ft.com3 Dirt-Cheap Drug Developers With Blockbuster PotentialJuly 11, 2024 | investorplace.com3 Next-Gen Drug Stocks Exploring Psychedelic FrontiersJuly 8, 2024 | investorplace.com3 Psychedelic Stocks to Ride to the Moon and BeyondJuly 6, 2024 | investorplace.com3 Psychedelic Stocks to Buy on the Dip: Summer 2024July 2, 2024 | investorplace.comatai Life Sciences CEO talks successful Phase 1 trial of IV psilocin formulation – ICYMIJune 29, 2024 | proactiveinvestors.comatai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives ConferenceJune 26, 2024 | globenewswire.comatai Life Sciences optimistic as IV psilocin shows promise in treating depression in early trialJune 20, 2024 | proactiveinvestors.comatai Life Sciences Announces Update on Beckley Psytech's Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2aJune 20, 2024 | globenewswire.comatai Life Sciences poised for success with rigorous clinical trialsJune 7, 2024 | proactiveinvestors.comatai Life Sciences to Participate in the Jefferies 2024 Global Healthcare ConferenceMay 31, 2024 | globenewswire.com Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼0.480.45▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼92▲ATAI Articles Average Week Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVDL News Today ZYME News Today SEPN News Today COGT News Today BCAX News Today BCYC News Today COLL News Today PAHC News Today IMTX News Today AVBP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
